Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HCFA Reorganized Into Three Centers, Given New Name

This article was originally published in The Gray Sheet

Executive Summary

The division of the Health Care Financing Administration's management responsibilities into three distinct centers represents the "first in a series of changes" to make the agency more beneficiary friendly and service oriented, HHS Secretary Tommy Thompson said June 14 in kicking off the restructuring.

You may also be interested in...



CLIA Moderate Complexity Provision Should Provide Rapid HIV Test Access

Expedited access to rapid HIV testing should be enabled under a special provision of the Clinical Laboratory Improvement Amendments (CLIA) moderate complexity test category, FDA's Blood Products Advisory Committee concluded June 14.

AHRQ Alzheimer's Diagnosis Technology Assessment To Focus On PET

The Agency for Healthcare Research & Quality's technology assessment on Alzheimer's disease diagnosis should include a systematic review of positron emission tomography studies as well as literature citations for other imaging modalities, according to the Medicare Coverage Advisory Commission's executive committee.

CLIA Moderate Complexity Provision Should Provide Rapid HIV Test Access

Expedited access to rapid HIV testing should be enabled under a special provision of the Clinical Laboratory Improvement Amendments (CLIA) moderate complexity test category, FDA's Blood Products Advisory Committee concluded June 14.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015018

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel